Merus' drug achieved an objective response rate of 33% and 40% in the two cancers, respectively, with durations of response of 7.4 months in lung cancer and between 3.7 months and 16.6 months in ...

Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to ...